Meningococcal serogroup C conjugate vaccine (Q34482078)

2 August 2017

1 reference

title

Meningococcal serogroup C conjugate vaccine (English)

1 reference

2 August 2017

Raman Lakshman

1

1 reference

2 August 2017

Adam Finn

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Expert Opinion on Biological Therapy

2 August 2017

published in

1 reference

2 August 2017

volume

2

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

87-96

1 reference

Bacterial meningitis in the United States in 1995. Active Surveillance Team

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Mortality in severe meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Complications and sequelae of meningococcalinfections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Vaccines for prevention of meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Importance of complement source in measuring meningococcal bactericidal titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Comparative studies on pharyngeal carriage of Neisseria meningitidis during a localized outbreak of serogroup C meningococcal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Carriage of Neisseria meningitidis and Neisseria lactamica in Infants and Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Safety of a new conjugate meningococcal C vaccine in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4 months of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

A randomised, double-blind, controlled trial of the immunogenicity and tolerability of a meningococcal group C conjugate vaccine in young British infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2.1.87

21 January 2018

Identifiers

DOI

10.1517/14712598.2.1.87

1 reference

2 August 2017

1 reference